CONMED Corporation
CNMDNYSEHealthcare● Active
$35.16
+$0.03(+0.09%)
Market Cap$1.1B
P/E Ratio—
52W High$60.35
52W Low$32.13
CONMED Corporation (CNMD) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · CNMD · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.37B | $1.31B | $1.24B | $1.05B | $1.01B |
| Cost of Revenue | $0.65B | $0.57B | $0.57B | $0.47B | $0.44B |
| Gross Profit | $0.73B | $0.73B | $0.68B | $0.57B | $0.57B |
| Gross Margin %(computed) | 52.77% | 56.08% | 54.33% | 54.64% | 56.21% |
| Operating Expenses | |||||
| R&D Expenses | $0.06B | $0.05B | $0.05B | $0.05B | $0.04B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.58B | $0.53B | $0.56B | $0.50B | $0.46B |
| Operating Income | $0.14B | $0.20B | $0.12B | $0.07B | $0.11B |
| Operating Margin %(computed) | 10.27% | 15.33% | 9.69% | 6.70% | 10.86% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.03B | $0.04B | $0.04B | $0.03B | $0.04B |
| Income Before Tax | $0.07B | $0.16B | $0.08B | ($0.07B) | $0.07B |
| Income Tax Expense | $0.02B | $0.03B | $0.02B | $0.01B | $0.01B |
| Net Income | $0.05B | $0.13B | $0.06B | ($0.08B) | $0.06B |
| Net Margin %(computed) | 3.42% | 10.13% | 5.18% | -7.71% | 6.19% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.52 | $4.29 | $2.10 | $-2.68 | $2.14 |
| Wtd Avg Shares | 0.03B | 0.03B | 0.03B | 0.03B | 0.03B |
| EBITDA | $0.19B | $0.27B | $0.19B | $0.01B | $0.18B |
| EBITDA Margin %(computed) | 14.08% | 20.82% | 15.46% | 0.75% | 17.74% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more CONMED Corporation data
About CONMED Corporation (CNMD) Income Statement
CONMED Corporation (CNMD) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, CNMD reported revenue of $1.37B, gross profit of $0.73B (gross margin 52.77%), and net income of $0.05B — a net profit margin of 3.42%.
Frequently asked questions
CNMD · 4 questionsCONMED Corporation (CNMD) reported revenue of $1.37B for 2025, up 5.2% year-over-year.
CNMD revenueCNMD salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08